Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Foehr Matthew W
Relationship:   President and CEO, Dir...
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   3,948,737    

Indirect Shares

   0      
Direct Value   $36,130,555    

Indirect Value

   $0      
Total Shares   3,948,737      
Total Value   $36,130,555      


Ligand Pharmaceuticals Inc $13,794,004 Viking Therapeutics, Inc. $6,926,425 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $15,349,126 Ligand Pharmaceuticals Inc $13,794,004 Viking Therapeutics, Inc. $6,926,425 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $15,349,126
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    4    

     Stock price went up :
    8   
    0    
     Stock price went down :
    5   
    4    
   
     Gain/Loss Ratio :
   1.6   
   -4.0   
     Percentage Gain/Loss :
   35.5%
 -89.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ligand Pharmaceuticals Inc LGND Former Executive Officer 2022-11-01 162,187 2011-04-18 0    Premium*  
            Viking Therapeutics, Inc. VKTX Director 2022-05-02 111,250 2015-05-04 0    Premium*  
            Qualigen Therapeutics Inc QLGN Director 2020-04-10 138,635 2015-06-24 0    Premium*  
            OmniAb, Inc OABI President and CEO, Dir... 2024-05-24 3,536,665 2022-11-01 0    Premium*  
* Premium Members only  

Records found :    136         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
QLGN Qualigen Therapeutics Inc Director   –       •      –    2016-01-08 4 B $1.64 $21,320 D/D 13,000 17,000 2.39 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-02-11 4 A $0.00 $0 D/D 5,676 78,304 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-02-15 4 D $85.97 $141,163 D/D (1,642) 76,662 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-03-17 4 S $96.70 $618,880 D/D (6,400) 76,662 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-03-17 4 OE $9.97 $86,241 D/D 8,650 78,912 0 -
VKTX Viking Therapeutics, Inc. Director   –       •      –    2016-04-13 4 B $1.24 $24,800 D/D 20,000 26,250 2.39 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-08-05 4 S $122.14 $1,526,750 D/D (12,500) 78,912 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-08-05 4 OE $9.97 $124,625 D/D 12,500 91,412 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2016-08-08 4 OE $9.97 $41,126 D/D 4,125 83,037 0 -
VKTX Viking Therapeutics, Inc. Director   –       •      –    2016-11-15 4 B $1.21 $15,678 D/D 13,000 39,250 2.39 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-02-15 4 D $104.28 $246,831 D/D (2,367) 80,670 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-02-24 4 A $0.00 $0 D/D 12,783 90,720 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-02-24 4 D $100.38 $274,339 D/D (2,733) 83,176 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-03-02 4 OE $9.97 $68,584 D/D 6,879 97,599 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-03-02 4 S $103.39 $711,214 D/D (6,879) 90,720 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-03-03 4 OE $9.97 $19,940 D/D 2,000 92,720 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-05-12 4 S $112.20 $630,650 D/D (5,621) 92,720 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-05-12 4 OE $9.97 $56,041 D/D 5,621 98,341 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-05-15 4 OE $9.97 $21,934 D/D 2,200 94,920 0 -
QLGN Qualigen Therapeutics Inc Director   –       •      –    2017-05-18 4 B $0.62 $11,155 D/D 18,000 35,000 2.39 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-08-09 4 S $127.51 $777,824 D/D (6,100) 94,920 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-08-09 4 OE $9.97 $69,292 D/D 6,950 95,770 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-12-28 4 D $138.66 $411,959 D/D (2,971) 98,494 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2017-12-28 4 A $0.00 $0 D/D 5,695 101,465 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2018-02-15 4 D $157.18 $575,750 D/D (3,663) 94,831 0 -
  136  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us